Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Nov 9, 2013, before the open
10-Q filed Nov 12, 2013, 43 days after period end · 0001299130-13-000011
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Revenue | $7.42M | $2.78M | $10.52M | $220.00K |
| Net Income | -$20.49M | -$22.73M | -$29.28M | -$40.71M |
| EPS Diluted | -$0.31 |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.41 |
| -$0.54 |
| -$39.70 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
